It’s Official: Teplizumab is Under Review by the FDA
The FDA regulatory review is now under way for teplizumab, to prevent or delay T1D in at-risk individuals. The target…
What We Can Be Proud Of in 2020
It’s been a tough year, to say the least. But there’s news that we can be proud of in type…
Breakthrough T1D Video: “Wouldn’t Have Happened Without Breakthrough T1D”
Dr. Robert Langer co-founded Moderna, who gained emergency use approval for its COVID vaccine. Watch the video to find out…
Discovery to Translation: Clinical Trial of a JAK Inhibitor in T1D
A Breakthrough T1D-funded clinical trial will test if a JAK inhibitor will preserve beta cell function in children and young…
Breakthrough T1D Video: “We’ve Been Too Focused on [Insulin]”
“We’ve been too focused on [insulin],” Jeremy Pettus, M.D., an endocrinologist at UC San Diego, says. Watch the video to…
What If You Could Halt Immune Cell Memory?
JDRF-funded researchers have discovered a protein on immune cells that, when it is disabled, could halt immune cell memory.
SFC Fluidics, a Breakthrough T1D Partner, Receives Breakthrough Device Designation
SFC Fluidics, a Breakthrough T1D partner, received a breakthrough device designation for its interoperable insulin delivery pod. How is it different? Find out here.
Breakthrough T1D Wins 2020 Amazon Web Services Imagine Grant for Nonprofits
Prestigious award recognizes nonprofit organizations using technology to solve the world’s most pressing challenges.
Aha! An Autoimmune Disease!
In 1974, two teams showed that diabetes is associated with antibodies against beta cells, which helped establish T1D as an…
Bringing T1D Screening to the Public with T1Detect
Breakthrough T1D is launching T1Detect, a community-based education and awareness program to expand screening to the general population.
